Procedure | Visit 1 Screening | Visit 2 Allocation | Visit 3 FU1a | Visit 4 FU 2b | Visit 5 FU 3c | Visit 6 FU 4d |
---|---|---|---|---|---|---|
Enrolment | ||||||
Eligibility screening | X | |||||
Informed consent | X | |||||
Randomization | X | |||||
Interventions | ||||||
Endoscopic endonasal transsphenoidal surgery | X | |||||
Sellar floor reconstruction/closure | X | |||||
Assessments | ||||||
Medical history | X | |||||
EQ-5D | X | X | X | X | X | |
VAS | X | X | X | X | X | |
SNOT-22 questionnaire | X | X | X | X | X | |
SBI | X | X | X | X | X | |
MR imaging | X | X | X | |||
Cost/material | X | |||||
Intraoperative CSF leakage | X | |||||
Nasal endoscopy to assess CSF leakage | X | X | X | X | ||
Nasal endoscopy to assess wound healing | X | X | X | X | ||
Nasal endoscopy to assess infection | X | X | X | X | ||
Assessment of adverse events | X | X | X | X | X |